Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Enrofloxacin
aniMedica GmbH
QJ01MA90
Enrofloxacin
100 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
enrofloxacin
Authorised
2012-04-20
Enrotron 100 mg/ml 1 von 17 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Enrotron 100 mg/ml Solution for injection for cattle, sheep, goats and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE Enrofloxacin 100.0 mg EXCIPIENTS 1-Butanol 30.0 mg For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection. Clear, slightly yellowish to yellowish orange solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle Sheep Goats Pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _ _ CATTLE Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of _Pasteurella multocida, Mannheimia haemolytica_ and _Mycoplasma _ spp. Treatment of acute severe mastitis caused by enrofloxacin susceptible strains of _Escherichia coli_ . Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli_ . Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli_ . Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of _Mycoplasma bovis_ in cattle less than 2 years old. SHEEP Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli_ . Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli_ . Treatment of mastitis caused by enrofloxacin susceptible strains of _Staphylococcus aureus_ and _Escherichia coli_ . Enrotron 100 mg/ml 2 von 17 GOATS Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of _Pasteurella multocida_ and _Mannheimia haemolytica_ . Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli_ . Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli_ . Treatment of mastitis caused by enrofloxacin susceptible strains of _Staphylococcus aureus_ and _Escherichia Read the complete document